Trial Profile
Multicentric Phase II Study of Concomitant Chemo-Radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-Radiotherapy by Weekly Cisplatin – Docetaxel- Consolidation Chemotherapy by Docetaxel.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2013
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 23 Jan 2008 The expected completion date for this trial is now 1 Mar 2007.
- 31 Oct 2007 Status changed from recruiting to discontinued
- 20 Sep 2006 New trial record.